XML 40 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Intangible Assets (Tables)
3 Months Ended
Sep. 30, 2024
Intangible Assets [Abstract]  
Schedule of Intellectual Property Capitalized

The acquired intellectual property relates to cancer stem cell technology, and is carried at its cost as at its date of acquisition, less accumulated amortization.

 

 

Cancer Stem
Cell Technology

 

Carrying amount at June 30, 2024

 

$

5,467,522

 

Amortization expense

 

 

(165,683

)

Carrying amount at September 30, 2024

 

$

5,301,839

 

 

 

 

 

Carrying amount at June 30, 2023

 

$

6,130,253

 

Amortization expense

 

 

(165,683

)

Carrying amount at September 30, 2023

 

$

5,964,570